Click For Photo: http://www.newsmax.com/CMSPages/GetFile.aspx?guid=e7dc8499-335b-46cc-be90-37d4989ca47b&SiteName=Newsmax&imgtype=.jpg
Generic biologic drugs are just as safe and effective as their brand-name counterparts at treating rheumatoid arthritis, inflammatory bowel disease, and psoriasis, a new study suggests.
The study by the Johns Hopkins Bloomberg School of Public Health examined multiple biologics, made from living cells, which are complicated to manufacture. The class of drugs represents a growing sector expected to reach 20 percent of the pharmaceutical market by 2017, according to a news release.
Study - Tuesday - Annals - Internal - Medicine
The study was published Tuesday in the Annals of Internal Medicine.
"The billion-dollar question has been whether these ‘generic biologics’ are the same as the brand-name versions," said study leader G. Caleb Alexander, MD, an associate professor in the Department of Epidemiology at the Bloomberg School and co-director of the Johns Hopkins Center for Drug Safety and Effectiveness. "The same debate occurred with the advent of less complicated generic drugs and now it’s being hashed out all over again with much more at stake...
Wake Up To Breaking News!